日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early-warning prediction of visceral leishmaniasis mortality using a multivariate STL-deep learning hybrid approach on 20 years of monthly time series

利用基于20年月度时间序列的多变量STL-深度学习混合方法对内脏利什曼病死亡率进行早期预警预测

El Guma, Fathelrhman; Awadalla, Maaweya; Al Rawi, Halah Z; Saeed, Bashayer; Alshanbari, Huda M; Shokeralla, Alshaikh A; Alosaimi, Bandar

Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination

不同 COVID-19 疫苗平台在同源/异源加强针后体液和细胞免疫持久性:接种疫苗后一年

Maaweya Awadalla, Halah Z AlRawi, Rahaf A Henawi, Fawziya Barnawi, Haitham Alkadi, Ahmed Alyami, Ammar Alsughayir, Alyazeed S Alsaif, Ayman Mubarak, Wael Alturaiki, Bandar Alosaimi

Comparing the influence of front-of-pack nutrition labels on Saudi consumers' understanding and food selection

比较包装正面营养标签对沙特消费者理解和食品选择的影响

AlQurashi, Alaa Ashraf; Marar, Sumayyia D; Ayyash, Mohsen; AlRawi, Halah Z; Abu-Shaheen, Amani

Crosstalk Between Immunity and Oncogenes Within the Tumor Microenvironment of HPV-Associated Cervical Squamous Cell Carcinoma

HPV相关宫颈鳞状细胞癌肿瘤微环境中免疫与癌基因的相互作用

Alahmadi, Reham M; Al Rawi, Halah Z; Awadalla, Maaweya; Saeed, Bashayer; Abdelazeem, Basma; Alshanbari, Huda M; Alosaimi, Bandar

Transcriptomic profile of the immune genes, oncogenes, and tumor suppressor genes in HPV associated Cervical Intraepithelial Neoplasia 3 (CIN 3) and Cervical Squamous Cell Carcinoma (CSCC): Comparable expressions indicative of invasive potential

HPV相关宫颈上皮内瘤变3级(CIN 3)和宫颈鳞状细胞癌(CSCC)中免疫基因、癌基因和抑癌基因的转录组谱:相似的表达提示侵袭性潜能

Awadalla, Maaweya; Al Rawi, Halah Z; Alahmadi, Reham M; Khojah, Osamah T; Al-Shouli, Samia T; Almansour, Mansour I; Alosaimi, Bandar

Association between receiving Covid-19 vaccine and menstrual cycle patterns among childbearing women: A cross-sectional study

新冠疫苗接种与育龄妇女月经周期模式之间的关联:一项横断面研究

AlRawi, Halah Z; AlQurashi, Alaa; AlDahan, Doaa; Alkhudhayri, Maha; Alsharidah, Amani R; Wani, Tariq; AlJaroudi, Dania

Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir

分析接受羟氯喹或法匹拉韦治疗的中重度 COVID-19 患者住院时间 (LOS) 的差异

Alosaimi, Bandar; Alshanbari, Huda M; Alturaiqy, Muath; AlRawi, Halah Z; Alamri, Saad; Albujaidy, Asma; Bin Sabaan, Aljawharah; Alrashed, Ahmed A; Alamer, Ahmad; Alghofaili, Fayez; Al-Duraymih, Khaled; Alshalani, Abdulaziz J; Alturaiki, Wael